Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Tamoxifen acts on Trypanosoma cruzi sphingolipid pathway triggering an apoptotic death process.

Landoni M, Piñero T, Soprano LL, Garcia-Bournissen F, Fichera L, Esteva MI, Duschak VG, Couto AS.

Biochem Biophys Res Commun. 2019 Aug 27;516(3):934-940. doi: 10.1016/j.bbrc.2019.06.149. Epub 2019 Jul 2.

PMID:
31277939
2.

Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.

Rial MS, Scalise ML, López Alarcón M, Esteva MI, Búa J, Benatar AF, Prado NG, Riarte AR, Fichera LE.

Parasitology. 2019 Mar;146(3):305-313. doi: 10.1017/S0031182018001567. Epub 2018 Oct 10.

PMID:
30301480
3.

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood.

Fernández ML, Hernández Y, Scollo K, Esteva MI, Riarte AR, Prado NG.

Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):557-559. doi: 10.1590/0037-8682-0364-2017.

4.

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.

Rial MS, Scalise ML, Arrúa EC, Esteva MI, Salomon CJ, Fichera LE.

PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0006119. doi: 10.1371/journal.pntd.0006119. eCollection 2017 Dec.

5.

Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): A potential novel tool for the detection of congenital Chagas infection.

Rivero R, Bisio M, Velázquez EB, Esteva MI, Scollo K, González NL, Altcheh J, Ruiz AM.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):26-28. doi: 10.1016/j.diagmicrobio.2017.06.012. Epub 2017 Jun 19.

PMID:
28684052
6.

Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.

Scalise ML, Arrúa EC, Rial MS, Esteva MI, Salomon CJ, Fichera LE.

Am J Trop Med Hyg. 2016 Aug 3;95(2):388-93. doi: 10.4269/ajtmh.15-0889. Epub 2016 May 31.

7.

Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.

Ferrero MR, Heins AM, Soprano LL, Acosta DM, Esteva MI, Jacobs T, Duschak VG.

Med Microbiol Immunol. 2016 Feb;205(1):21-35. doi: 10.1007/s00430-015-0421-2. Epub 2015 Jun 6.

PMID:
26047932
8.

Predictive role of polymerase chain reaction in the early diagnosis of congenital Trypanosoma cruzi infection.

Velázquez EB, Rivero R, De Rissio AM, Malagrino N, Esteva MI, Riarte AR, Ruiz AM.

Acta Trop. 2014 Sep;137:195-200. doi: 10.1016/j.actatropica.2014.05.016. Epub 2014 Jun 2.

PMID:
24892867
9.

Effects of chlorate on the sulfation process of Trypanosoma cruzi glycoconjugates. Implication of parasite sulfates in cellular invasion.

Ferrero MR, Soprano LL, Acosta DM, García GA, Esteva MI, Couto AS, Duschak VG.

Acta Trop. 2014 Sep;137:161-73. doi: 10.1016/j.actatropica.2014.05.014. Epub 2014 May 28.

PMID:
24879929
10.

Solanesyl diphosphate synthase, an enzyme of the ubiquinone synthetic pathway, is required throughout the life cycle of Trypanosoma brucei.

Lai DH, Poropat E, Pravia C, Landoni M, Couto AS, Rojo FG, Fuchs AG, Dubin M, Elingold I, Rodríguez JB, Ferella M, Esteva MI, Bontempi EJ, Lukes J.

Eukaryot Cell. 2014 Feb;13(2):320-8. doi: 10.1128/EC.00271-13. Epub 2013 Dec 27.

11.

Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults.

Albareda MC, De Rissio AM, Tomas G, Serjan A, Alvarez MG, Viotti R, Fichera LE, Esteva MI, Potente D, Armenti A, Tarleton RL, Laucella SA.

PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2575. doi: 10.1371/journal.pntd.0002575. eCollection 2013.

12.

An anionic synthetic sugar containing 6-SO3 -NAcGlc mimics the sulfated cruzipain epitope that plays a central role in immune recognition.

Couto AS, Soprano LL, Landoni M, Pourcelot M, Acosta DM, Bultel L, Parente J, Ferrero MR, Barbier M, Dussouy C, Esteva MI, Kovensky J, Duschak VG.

FEBS J. 2012 Oct;279(19):3665-3679. doi: 10.1111/j.1742-4658.2012.08728.x. Epub 2012 Sep 4.

13.

Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates.

Acosta DM, Soprano LL, Ferrero MR, Esteva MI, Riarte A, Couto AS, Duschak VG.

Parasite Immunol. 2012 Nov;34(11):499-510. doi: 10.1111/j.1365-3024.2012.01378.x.

14.

A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin.

Acosta DM, Soprano LL, Ferrero M, Landoni M, Esteva MI, Couto AS, Duschak VG.

Parasite Immunol. 2011 Jul;33(7):363-70. doi: 10.1111/j.1365-3024.2011.01291.x.

15.

Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark.

Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL.

J Control Release. 2010 Nov 1;147(3):368-76. doi: 10.1016/j.jconrel.2010.08.014. Epub 2010 Aug 19.

PMID:
20727925
16.

Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina.

De Rissio AM, Riarte AR, García MM, Esteva MI, Quaglino M, Ruiz AM.

Am J Trop Med Hyg. 2010 May;82(5):838-45. doi: 10.4269/ajtmh.2010.08-0383. Erratum in: Am J Trop Med Hyg. 2010 Jun;82(6):1202.

17.

Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice.

Acosta DM, Arnaiz MR, Esteva MI, Barboza M, Stivale D, Orlando UD, Torres S, Laucella SA, Couto AS, Duschak VG.

Int Immunol. 2008 Apr;20(4):461-70. doi: 10.1093/intimm/dxm149. Epub 2008 Jan 14.

PMID:
18195050
18.

Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.

García GA, Arnaiz MR, Esteva MI, Laucella SA, Garavaglia PA, Ibarra SE, Ruiz AM.

Parasitology. 2008 Mar;135(3):347-57. Epub 2007 Nov 9.

PMID:
17991305
19.

Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).

Güida MC, Esteva MI, Camino A, Flawiá MM, Torres HN, Paveto C.

Exp Parasitol. 2007 Oct;117(2):188-94. Epub 2007 May 16.

PMID:
17673202
20.

Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.

García GA, Arnaiz MR, Laucella SA, Esteva MI, Ainciart N, Riarte A, Garavaglia PA, Fichera LE, Ruiz AM.

Parasitology. 2006 Jun;132(Pt 6):855-66. Epub 2006 Feb 15.

PMID:
16478565
21.

Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.

Esteva MI, Kettler K, Maidana C, Fichera L, Ruiz AM, Bontempi EJ, Andersson B, Dahse HM, Haebel P, Ortmann R, Klebe G, Schlitzer M.

J Med Chem. 2005 Nov 17;48(23):7186-91.

PMID:
16279776
22.

Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins.

Paveto C, Güida MC, Esteva MI, Martino V, Coussio J, Flawiá MM, Torres HN.

Antimicrob Agents Chemother. 2004 Jan;48(1):69-74.

23.

Trypanocidal effect of SKF525A, proadifen, on different developmental forms of Trypanosoma cruzi.

Franke De Cazzulo BM, Bernacchi A, Esteva MI, Ruiz AM, Castro JA, Cazzulo JJ.

Medicina (B Aires). 1998;58(4):415-8.

PMID:
9816705
24.

[Molecular and immunologic bases for the development of a vaccine against Chagas disease].

Segura EL, Cardoni RL, Búa J, Rottenberg ME, Bontempi EJ, Esteva MI, Carlomagno MA, De Titto EH, Ruiz AM.

Medicina (B Aires). 1989;49(3):203-9. Spanish.

PMID:
2518642

Supplemental Content

Loading ...
Support Center